Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1958 3
1959 1
1962 3
1965 1
1966 1
1968 1
1969 3
1970 1
1971 3
1973 1
1977 1
1978 2
1979 1
1980 4
1981 5
1982 4
1983 4
1984 5
1985 7
1986 5
1987 7
1988 6
1989 9
1990 12
1991 15
1992 19
1993 15
1994 17
1995 20
1996 17
1997 16
1998 14
1999 14
2000 15
2001 10
2002 13
2003 7
2004 15
2005 16
2006 20
2007 23
2008 39
2009 31
2010 52
2011 50
2012 52
2013 76
2014 46
2015 31
2016 52
2017 45
2018 39
2019 38
2020 44
2021 47
2022 36
2023 48
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

1,003 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Wakita S, et al. Among authors: uchiyama h. Blood Adv. 2022 Jan 11;6(1):238-247. doi: 10.1182/bloodadvances.2021004292. Blood Adv. 2022. PMID: 34448807 Free PMC article.
Interlaboratory evaluation of LC-MS-based biomarker assays.
Saito K, Goda R, Arai K, Asahina K, Kawabata M, Uchiyama H, Andou T, Shimizu H, Takahara K, Kakehi M, Yamauchi S, Nitta SI, Suga T, Fujita H, Ishikawa R, Saito Y. Saito K, et al. Among authors: uchiyama h. Bioanalysis. 2024 Mar;16(6):389-402. doi: 10.4155/bio-2023-0173. Epub 2024 Feb 9. Bioanalysis. 2024. PMID: 38334082 Review.
Impact of multiple H/D replacements on the physicochemical properties of flurbiprofen.
Uchiyama H, Ban K, Nozaki S, Ikeda Y, Ishimoto T, Fujioka H, Kamiya M, Amari R, Tsujino H, Arai M, Yamazoe S, Maekawa K, Kato T, Doi M, Kadota K, Tozuka Y, Tomita N, Sajiki H, Akai S, Sawama Y. Uchiyama H, et al. RSC Med Chem. 2023 Oct 23;14(12):2583-2592. doi: 10.1039/d3md00357d. eCollection 2023 Dec 13. RSC Med Chem. 2023. PMID: 38107175
A tailored tetravalent peptide displays dual functions to inhibit amyloid β production and aggregation.
Sato W, Watanabe-Takahashi M, Murata T, Utsunomiya-Tate N, Motoyama J, Anzai M, Ishihara S, Nishioka N, Uchiyama H, Togashi J, Nishihara S, Kawasaki K, Saito T, Saido TC, Funamoto S, Nishikawa K. Sato W, et al. Among authors: uchiyama h. Commun Biol. 2023 Apr 8;6(1):383. doi: 10.1038/s42003-023-04771-9. Commun Biol. 2023. PMID: 37031306 Free PMC article.
[Coronary Aneurysm with Fistula].
Sakurada T, Uchiyama H, Maeda T, Muraki S, Nakashima S, Araki E. Sakurada T, et al. Among authors: uchiyama h. Kyobu Geka. 2021 Nov;74(12):987-991. Kyobu Geka. 2021. PMID: 34795139 Japanese.
Femoropopliteal Bypasses with Varicose Great Saphenous Vein.
Kuma S, Iwasa K, Matsumoto T, Uchiyama H. Kuma S, et al. Among authors: uchiyama h. Ann Vasc Dis. 2022 Jun 25;15(2):138-141. doi: 10.3400/avd.cr.21-00120. Ann Vasc Dis. 2022. PMID: 35860823 Free PMC article.
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia.
Wakita S, Marumo A, Morita K, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Nakayama K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Tashiro H, Sakaguchi M, Yui S, Arai K, Kitano T, Miyata M, Arai H, Kanda M, Itabashi K, Fukuda T, Kanda Y, Yamaguchi H. Wakita S, et al. Among authors: uchiyama h. Cancer Sci. 2023 Apr;114(4):1297-1308. doi: 10.1111/cas.15720. Epub 2023 Jan 27. Cancer Sci. 2023. PMID: 36610002 Free PMC article.
The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study.
Miyakawa Y, Imada K, Ichikawa S, Uchiyama H, Ueda Y, Yonezawa A, Fujitani S, Ogawa Y, Matsushita T, Asakura H, Nishio K, Suzuki K, Hashimoto Y, Murakami H, Tahara S, Tanaka T, Matsumoto M. Miyakawa Y, et al. Among authors: uchiyama h. Int J Hematol. 2023 Mar;117(3):366-377. doi: 10.1007/s12185-022-03495-6. Epub 2022 Nov 24. Int J Hematol. 2023. PMID: 36427162 Free PMC article. Clinical Trial.
1,003 results